Don sits down with friend of the show Dr. Frita to break down the latest developments in pharmaceuticals, and the policy shifts shaping them. From growing skepticism around antidepressants to reports of unconventional partnerships influencing drug approvals, the Trump administration is making moves that are raising serious questions. What’s driving these decisions, and what could they mean for patients and public health moving forward? Learn more about your ad choices. Visit megaphone.fm/adchoices